iCeutica

iCeutica is a pharmaceutical product development company headquartered in Princeton, New Jersey, in the United States, with an Australian registered office in Joondalup, Western Australia. The company describes itself as a leading product development company that leverages the power of its proprietary SoluMatrix Fine Particle Technology to create new and improved pharmaceuticals. Its stated mission is to make drugs better by enabling meaningful clinical benefits and creating new intellectual property protection. iCeutica's core asset is SoluMatrix Fine Particle Technology, a proprietary formulation technology that reduces drug particle size to improve the performance of pharmaceutical products. According to the company, this technology can create new drugs with improved efficacy, better side effect profiles and more convenient dosing. The technology is applied across several therapeutic areas, including pain and inflammation, oncology, and respiratory diseases. The company operates through two complementary models. First, it works with pharmaceutical partners to create new branded medicines by combining SoluMatrix technology with the partners' product experience and commercial insights. iCeutica has worked with companies including Iroko Pharmaceuticals on NSAIDs and Churchill Pharmaceuticals on oncology agents, and states that a number of FDA-approved and late-stage products in development utilize its SoluMatrix technology. Second, iCeutica advances its own pipeline of product candidates addressing broad indications such as pain and inflammation, oncology, and respiratory diseases. In addition to technology licensing and partnered development, iCeutica provides a range of services to pharmaceutical customers, integrating performance enhancement of drug products with formulation development, analytical analysis, method development, prototyping and manufacturing capabilities. The company positions itself as a cost-effective and reliable development partner that can rapidly move from concept to clinical trial material. iCeutica's corporate directory lists a US corporate office at 116 Village Blvd., Suite 200, Princeton, NJ 08540, and an Australian registered office at PO Box 214, Joondalup DC, Western Australia 6919. The company is associated with patent attorneys Fish & Richardson in Boston, Massachusetts, and Wrays in West Perth, Western Australia. Public information about the company's ownership, founding date and financial status is limited.

iCeutica is a pharmaceutical product development company headquartered in Princeton, New Jersey, United States, with an Australian registered office in Joondalup, Western Australia. The company's public materials describe it as a leading product development company that leverages the power of its proprietary SoluMatrix Fine Particle Technology to create new and improved pharmaceuticals. The company's central technology, SoluMatrix Fine Particle Technology, is a proprietary formulation platform that reduces drug particle size to improve the performance of pharmaceutical products. According to iCeutica, the technology can create new drugs with improved efficacy, better side effect profiles and more convenient dosing. The company states that there are numerous FDA-approved and late-stage products in development that utilize SoluMatrix technology. iCeutica operates through a combination of partnered development and its own pipeline. It works with pharmaceutical partners to create new branded medicines by combining SoluMatrix technology with the partners' product experience and commercial insights. The company has successfully worked in partnership with a number of companies, including Iroko Pharmaceuticals on NSAIDs and Churchill Pharmaceuticals on oncology agents, to develop and gain approval for a number of FDA-approved medicines. In addition to its work with partners, iCeutica advances its own pipeline of product candidates addressing broad indications including pain and inflammation, oncology, and respiratory diseases. The company also provides development services to pharmaceutical customers. It integrates performance enhancement of drug products with superior formulation development, analytical analysis, method development, prototyping and manufacturing capabilities, positioning itself as a cost-effective and reliable development partner. Its teams are led and staffed by experienced industry professionals, and the company states it can rapidly move from concept to clinical trial material. iCeutica's corporate directory lists a US corporate office at 116 Village Blvd., Suite 200, Princeton, NJ 08540, and an Australian registered office at PO Box 214, Joondalup DC, Western Australia 6919. The company is associated with patent attorneys Fish & Richardson in Boston, Massachusetts, and Wrays in West Perth, Western Australia. Public information about the company's founding date, ownership structure and financial status is limited.

A pharmaceutical product development company that uses its proprietary SoluMatrix Fine Particle Technology to create new and improved medicines with partners and through its own pipeline, positioning itself as a cost-effective and reliable development partner.

• SoluMatrix Fine Particle Technology

  iCeutica's proprietary formulation technology that creates new drugs with improved efficacy, better side effect profiles and more convenient dosing.

• Pain and inflammation product candidates

  Pipeline candidates using SoluMatrix technology that can dramatically increase the speed-of-action of a pain drug, often at much lower doses than current dosages and with potentially fewer side effects than full-dose products.

• Oncology product candidates

  Pipeline candidates using SoluMatrix technology to create improved cancer drugs with potentially enhanced properties, such as significantly reduced dose required to achieve a therapeutic level of the drug, reduced side effects and potentially improved efficacy.

• Respiratory disease product candidates

  Pipeline candidates addressing respiratory diseases, where one of the key challenges is formulating inhalable medicines to achieve consistent performance.

1. 1iCeuticaiceutica.com
2. 2About Us - iCeuticaiceutica.com
3. 3Services - iCeuticaiceutica.com
4. 4Products - iCeuticaiceutica.com
5. 5iCeutica (United States) - Wikidatawikidata.org